Ripple Mapping for Epicardial Mapping of Brugada Syndrome

Ripple-Mapping for the Detection of Long Duration Action Potential Areas in Patients With Brugada Syndrome

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03435393

Enrollment

Registered

2018-02-19

Start date

2017-09-01

Completion date

2020-09-30

Last updated

2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brugada Syndrome

Brief summary

Whether a mapping algorithm Ripple-mapping is able to rapidly identify the areas of long-duration multicomponent electrograms which constitute the targets for ablation for an automated strategy remains to be assessed.

Interventions

PROCEDURECatheter ablation

Mapping of the epicardium and ablating areas of long fractionated potentials

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Brugada syndrome patients requiring ablation

Exclusion criteria

* Patients not able to consent

Design outcomes

Primary

Measure	Time frame	Description
Eradication of Brugada syndrome pattern	24h post procedure	Disappearance of type 1 Brugada pattern on post-procedure ECG

Secondary

Measure	Time frame	Description
Freedom from ventricular arrhythmias	12 months post-procedure	No documentation of sustained ventricular tachycardia or ventricular fibrillation

Countries

Brazil, Portugal, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026